EP 3890732 A4 20220824 - INJECTABLE FORMULATIONS
Title (en)
INJECTABLE FORMULATIONS
Title (de)
INJIZIERBARE FORMULIERUNGEN
Title (fr)
FORMULATIONS INJECTABLES
Publication
Application
Priority
- US 201862775779 P 20181205
- US 2019064669 W 20191205
Abstract (en)
[origin: WO2020118045A1] The present disclosure relates to therapeutic compounds and formulations for treating, reducing the risk of, or for preventing a disease, disorder, or condition characterized by the presence of toxic aldehydes.
IPC 8 full level
A61K 31/423 (2006.01); A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 31/47 (2006.01); A61P 27/02 (2006.01)
CPC (source: EP US)
A61K 9/0019 (2013.01 - EP US); A61K 9/127 (2013.01 - EP US); A61K 9/1611 (2013.01 - US); A61K 9/1647 (2013.01 - US); A61K 9/5031 (2013.01 - US); A61K 31/423 (2013.01 - EP US); A61K 31/428 (2013.01 - EP); A61K 31/47 (2013.01 - EP); A61K 47/02 (2013.01 - US); A61K 47/24 (2013.01 - US); A61K 47/28 (2013.01 - US); A61K 47/40 (2013.01 - EP US); A61P 27/02 (2017.12 - EP US)
Citation (search report)
- [XY] KR 20180073554 A 20180702 - ALDEYRA THERAPEUTICS INC [US]
- [XY] WO 2018039197 A1 20180301 - ALDEYRA THERAPEUTICS INC [US]
- [Y] CA 3032609 A1 20180301 - ALDEYRA THERAPEUTICS INC [US]
- [Y] US 2018250306 A1 20180906 - BRADY TODD [US], et al
- See references of WO 2020118045A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2020118045 A1 20200611; EP 3890732 A1 20211013; EP 3890732 A4 20220824; JP 2022511030 A 20220128; US 2022133697 A1 20220505
DOCDB simple family (application)
US 2019064669 W 20191205; EP 19891719 A 20191205; JP 2021531725 A 20191205; US 201917299731 A 20191205